Pathway – an AI-driven medical knowledge platform – recently announced it has secured $5 million in seed funding to advance its solutions to information overload among healthcare professionals. And Pathway distills practice guidance from millions of evidence-based sources into concise summaries, helping clinicians stay up-to-date and provide efficient, high-quality care.
The seed funding round was led by Yamaha Motor Ventures and joined by Verge HealthTech Fund, with participation from existing investors Amplify Capital, BoxOne Ventures, and Formentera Capital. And the funding round also received the backing of several physicians who have experienced the benefits and transformative potential of Pathway firsthand.
Medical knowledge has been growing at an unprecedented rate, intensifying the issues faced by busy clinicians who must adapt to this phenomenon while being asked to see more patients in less time. And in response to the significant demand from its 350,000+ registered healthcare professionals, Pathway is making its clinical decision support tool open access, ensuring more professionals benefit from quality medical evidence worldwide.
Plus, the company is unveiling Pathway AI in limited beta, its most advanced AI assistant and search tool to date, designed to help clinicians with nuanced medical queries. And Pathway’s clinical AI assistant recently showcased its abilities by scoring higher than 97% of human test takers on the US Medical Licensing Examination (USMLE), surpassing the accuracy of MedPaLM 2, Google’s flagship medical LLM, on this benchmark.
Pathway’s goal of improving the daily experience of clinicians has made its platform the fastest-growing network of verified clinicians. And with this new round of funding, Pathway will continue to improve its technology and enable more clinicians worldwide to stay current and make informed decisions for their patients.
KEY QUOTES:
“Pathway is quickly establishing itself as the go-to resource for healthcare professionals who need fast, evidence-based answers to their everyday questions. We and our investors share a vision to transform how medical knowledge is organized and delivered through the power of AI. This funding will accelerate the rollout of Pathway’s technology and amplify our reach to clinicians globally.”
- Jonathan Hershon, CEO of Pathway
“Pathway AI combines the efficiency of Large Language Models (LLMs) with our vast database of physician-vetted data, empowering clinicians with transparent and actionable answers in seconds.”
“We believe that medical knowledge should be open and accessible. Our mission with Pathway is to expand this access, ensuring every clinician has the tools they need to provide the best care possible.”
- Dr. Louis Mullie, co-founder of Pathway
